Texas Vitamin Co., RSR Laboratories Inc.; Proposal to Withdraw Approval of New Animal Drug Applications; Opportunity for Hearing

摘要

The Food and Drug Administration (FDA) is providing an opportunity for hearing on a proposal to withdraw approval of new animal drug application (NADA) 117-688 held by Texas Vitamin Co. and NADA 140-850 held by RSR Laboratories Inc., because the applicants have failed to submit required periodic reports. FDA has been unable to locate the firms and to contact them at their previous business addresses.